Already registered for Bio€quity Europe?

In-Person Passes Sold Out; Register for Digital Pass (May 2, 2022) Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass. The Digital Pass allows you to schedule virtual 1x1 meetings with Bio€quity delegates over two bonus days (May 23-24), plus watch all session & presentation recordings for 30 days after the event. Digital attendees also receive BioCentury’s 2nd Annual Scene Setter report, McKinsey’s Bio€quity conference report and complimentary access to BioCentury’s BCIQ database.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan*, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1x1 meetings.

* Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass.

Navigating Through Talent & Capital Headwinds

  • Bio€quity Europe revives face-to-face financial networking in 2022 with “Navigating Through Talent & Capital Headwinds.”
  • Rich in science and benefitting from the recent global flood of capital, European biotech now faces two headwinds: The Talent Crunch and prospects of a Capital Crunch.
  • The Talent Crunch: European biotech faces the hard reality faced everywhere: Talent has become the rate-limiting factor to building a globally competitive innovation ecosystem.
  • The Capital Crunch: After the longest bull run in biotech history, concerns are rising - What will it take to keep investors in the sector?
  • Once again, Bio€quity Europe challenges its community to identify solutions to industry pain points, and to build a strategy that will sustain Europe’s innovation engine into the future.

Join your colleagues for the 22nd Bio€quity Europe as biopharma leaders debate industry headwinds, and discuss how to gain the upper hand in a global competition for talent and capital.

Why Attend?

  • Debate strategies for navigating through talent and capital headwinds over two-plus days of strategic panels and workshops.
  • Understand key talent and capital trends via an exclusive report from Insights Partner, McKinsey & Co.
  • Hear from 100+ rising biotechs selected by the BioCentury team.
  • Meet 1x1 with potential investors and partners using EBD's partneringONE® System – two days in-person (May 17-18), plus two days digital (May 23-24).
  • Network with peers from across the innovation ecosystem.
  • Use BioCentury’s BCIQ database to research companies and help prepare for 1x1 meetings.
  • Watch all session/presentation recordings for 30 days after the event.
  • Your choice: Full-Access Pass* or Digital Pass?
    * Due to record demand, Bio€quity Europe in Milan is sold out. We encourage you to register instead for a Digital Access Pass.

Explore Bio€quity Europe

Bio€quity Europe 2022 will be held at the Meliá Milano - May 16-18, 2022Meliá Milano Via Masaccio, 19, 20149 Milano MI, Italy

Bio€quity Europe 2022 Faculty

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
Alexandra Zemp, Ph.D.
McKinsey & Company
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Valerio De Molli
Managing Partner & CEO
The European House - Ambrosetti
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
View More Facultyright-arrow

Bio€quity Europe 2022 Sponsors

Sponsorship opportunities available for Bio€quity Europe 2022Speak with a BioCentury representative today

Bio€quity Europe 2022 Presenters

Interested in becoming a Presenting Company for the next Bio€quity Europe in Milan?Apply now to be considered for the Bio€quity Europe Class of 2022


“Bio€quity brings together top stakeholders in the life sciences European VC space. The event stands out by delivering quality thought leadership. For the biotech VC community, this is Europe’s flagship event.” 

Nanna Lüneborg, Ph.D.
General Partner

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners

"Bio€quity is the leading event for the biotech industry in Europe. A masterfully organized event, it brings all actors together and creates an atmosphere and platform for true networking and business development. Complement that with a rich insights agenda that materially contributes to the discussion in the industry and the region, and you have an unmissable event." 

Jorge Santos da Silva, Ph.D.
MoonLake Immunotherapeutics AG

"Bio€quity Europe is a great meeting for strategic discussions about access to capital and talent. It’s also a key networking event for investors and biopharma executives in Europe."​

Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics